Sanofi Consumer — 360° view

Sanofi Consumer, a company in the Pharmaceuticals industry, reported revenue of ₹263 crore and net profit of ₹77 crore for the September 2026 quarter.

Sanofi Consumer (NSE: SANOFICONR) closed at ₹3,442.40 on 20 Nov 2026, down 27.5% over the past year. Its market capitalisation is ₹7,928 crore and it trades at 28.3 times earnings.

Share price
₹3,442.40 (20 Nov 2026)
Market cap
₹7,928 Cr (20 Nov 2026)
P/E
28.34 (20 Nov 2026)
Revenue
₹263 Cr (September 2026 quarter)
Net profit
₹77 Cr (September 2026 quarter)
ROCE
89.9% (FY25)
ROE
71.6% (FY25)
Book value
₹151 (FY25)
Dividend yield
2.18% (last 12 months to 20 Nov 2026)
52-week high / low
₹5,255.00 / ₹3,168.20 (20 Nov 2026)
1-year return
-27.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SANOFICONR

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products. It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.